Related Experiment Video
Updated: Jan 19, 2026

Reducing State Anxiety Using Working Memory Maintenance
Published on: July 19, 2017
Dcf1 Affects Memory and Anxiety by Regulating NMDA and AMPA Receptors
Yajiang Wang1, Qiang Liu1, Jiayang Xie1
1Laboratory of Molecular Neural Biology, School of Life Sciences, Shanghai University, 381 Nanchen Road, Shanghai, 200444, China.
Abstract:
The hippocampus is critical for memory and emotion and both N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid (AMPA) receptors are known to contribute for those processes. However, the underlying molecular mechanisms remain poorly understood. We have previously found that mice undergo memory decline upon dcf1 deletion through ES gene knockout. In the present study, a nervous system-specific dcf1 knockout (NKO) mouse was constructed, which was found to present severely damaged neuronal morphology. The damaged neurons caused structural abnormalities in dendritic spines and decreased synaptic density. Decreases in hippocampal NMDA and AMPA receptors of NKO mice lead to abnormal long term potentiation (LTP) at DG, with significantly decreased performance in the water maze, elevated- plus maze, open field and light and dark test. Investigation into the underlying molecular mechanisms revealed that dendritic cell factor 1 (Dcf1) contributes for memory and emotion by regulating NMDA and AMPA receptors. Our results broaden the understanding of synaptic plasticity's role in cognitive function, thereby expanding its known list of functions.
Related Concept Videos
08:17Reducing State Anxiety Using Working Memory Maintenance
10:34A High-content Assay for Monitoring AMPA Receptor Trafficking
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
06:42Application of a NMDA Receptor Conductance in Rat Midbrain Dopaminergic Neurons Using the Dynamic Clamp Technique
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

